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Genetic alterations within the retinoblastoma locus in colorectal
carcinomas. Relation to DNA ploidy pattern studied by flow cytometric
analysis
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Summary Alterations within the retinoblastoma (Rb) gene, as detected by the VNTR probe p68RS2.0, and
flow cytometric DNA pattern have been analysed in 255 colorectal carcinomas. A total of 35.3% of the
tumours had alterations within the Rb gene. Amplification of one allele was demonstrated in 29.5% of the
tumours, and loss of heterozygosity was found in 11.5%. No association was found between amplification
within the Rb gene and clinicopathological characteristics of the patients. The high frequency of alterations
demonstrated within the Rb gene, suggests that this gene is involved in colorectal carcinogenesis with
amplification as by far the most abundant genetic alteration. This may imply that the Rb gene has an
oncogene-like function in colorectal carcinomas, rather than acting as a tumour suppressor gene. Sixty-three
per cent of the carcinomas were DNA aneuploid, and a significant association was demonstrated between
amplification within the Rb gene and DNA aneuploidy (P<0.01). Two other chromosome loci were analysed,
on chromosome lp (probe pYNZ2) and on chromosome 2p (probe pYNH24), respectively. On chromosome
lp, heterozygous loss was found in 22.2% of the tumours, indicating an involvement of this chromosome in a
subset of colorectal carcinomas.
Recent studies have demonstrated that several genetic altera-
tions may be involved in tumour development in the colorec-
tum (for review, see Fearon & Vogelstein, 1990). A consistent
observation is the loss or functional inactivation of several
chromosome loci presumed to contain tumour suppressor
genes. Loss of loci on chromosomes 5, 17 and 18, as well as
mutations in the ras gene and the p53 gene have been
reported (Muleris et al., 1985; Fearon et al., 1987; Vogelstein
et al., 1988; Lothe et al., 1988; Okamoto et al., 1988; Law et
al., 1988; Soussi et al., 1990; Baker et al., 1990), and it has
been demonstrated that these changes often appear in a
sequential manner, paralleling the clinical advancement of
the tumours (Vogelstein et al., 1988).
The retinoblastoma (Rb) gene is located on chromosome
band 13ql4.2. Loss or inactivation of this gene has been
demonstrated in several human malignancies (for reviews, see
Benedict et al., 1990; Marshall, 1991). The Rb gene has been
shown to suppress tumour development (Bookstein et al.,
1990), and the gene is therefore classified as a tumour sup-
pressor gene. Little is known about the involvement of this
gene in colorectal tumourigenesis. However, in a small series
of colorectal carcinomas, it has recently been reported a
significant amplification of the Rb gene (Gope et al., 1990).
In DNA flow cytometric assays, the total DNA content of
the main cell populations of tumours is quantified. Demon-
stration of an aneuploid DNA pattern reflects gross chromo-
somal changes, and may indicate genetic instability in the
tumour cells (Rognum et al., 1983; Meling et al., 1991).
Furthermore, the presence of aneuploidy is an important
prognostic variable in colorectal carcinomas (Wolley et al.,
1982; Armitage et al., 1985; Rognum et al., 1987, Rognum et
al., 1991).
In 255 colorectal carcinomas, we have studied Rb gene
alterations using Southern analysis, and DNA ploidy pattern
using flow cytometric analysis, and examined the relationship
between these two variables.
Materials and methods
Patients and tumour samples
Fresh tissue samples from 255 colorectal adenocarcinomas
removed during laparotomy from 129 men and 126 women
were studied. Nine patients had more than one carcinoma
synchronously. From these patients, only one tumour
(chosen at random) was studied to ensure mutual indepen-
dence of the tumours included. Clinicopathological charac-
teristics of the patients are listed in Table I.
Single cell suspensions were prepared either immediately
after tumour excision or after overnight storage in ice-cold
phosphate-buffered saline (PBS), pH 7.6. The tumour sam-
ples were mechanically minced in PBS, followed by nylon
mesh filtration (mesh pore size 70gm) (Seidengazefabrik AG
Thal, Switzerland). The cells were both fixed and stored in
70% ethanol at 4°C, until flow cytometric analysis or DNA
extraction was performed.
To evaluate the contamination of normal cells in the
tumour cell suspensions, cytospin preparations were made
from ethanol fixed cell suspensions from 18 of the tumours.
The cells were stained according to a modified Papanicolaou
method (Lexow, 1989). A minimum of 300 cells from each
tumour were evaluated and classified as either tumour cells,
mononuclear leukocytes, granulocytes, or cells of undeter-
mined origin, according to standard cytological criteria
(Koss, 1968).
To evaluate intratumoural variation, two to five samples
from each of eight carcinomas were analysed for DNA alter-
ations.
Southern analysis
Nuclear DNA was extracted from both tumour cell suspen-
sions and from peripheral blood leukocytes in a 340A
Nucleic Extractor (Applied Biosystem, Rotterdam, The
Netherlands), using standard methods (phenol-chloroform
extraction and ethanol precipitation) (Kunckel et al., 1977).
DNA samples (7.5jig) were digested to completion with
approximately eight times excess of the restriction enzymes
RsaI, PvuII, and MspI (Amersham, Buckinghamshire, Eng-
land), respectively. RsaI digested DNA was electrophoresed
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Table I Clinicopathological characteristics of the 255 colorectal
carcinoma patients
Clinicopathological characteristics
Dukes' stage" A
B
C
D
Histological gradeb
Well differentiated
Moderately differentiated
Poorly differentiated
Degree ofcellular atypiac
Slight cellular atypia
Moderate cellular atypia
Severe cellular atypia
Localisationd
Right colon
Left colon
Rectum
No. oftumours (%)
34 (13%)
110 (43.2%)
76 (29.8%)
35 (13.7%)
13 (5.1%)
207 (81.2%)
35 (13.7%)
8 (3.1%)
172 (67.5%)
75 (29.4%)
79 (31.0%)
64 (25.1%)
112 (43.9%)
aAccording to the modified Dukes' classification (Dukes, 1932;
Turnbull etal., 1967); bAccording tothecriteriaoftheWHO(Morson&
Sobin, 1976); cAccording to standard cytological criteria (Koss, 1966);
dCarcinomas in the colon located proximal and distal to the midtrans-
verse colon, are classified right- and left-sided, respectively.
on 2.0% NuSieve agarose gels (Bio Products, Vallenback
Strand, Denmark) for 60 h at 38 V. The digests of PvuII and
MspI were separated in 1.0% agarose gels (Sigma Chemical
Co., St. Louis, MO, USA) for 30 h at 48 V. The DNA was
transferred onto Nylon membranes (Bio-Rad, Richmond,
CA, USA) according to a slightly modified Southern proce-
dure (Southern, 1975), using alkaline solution (0.4 M NaOH
and 0.6 M NaCl). Southern blots of RsaI digested DNA were
hybridised with the probe p68RS2.0 which detects a variable
number of tandem repeat (VNTR) region in an intron of the
Rb gene (Wiggs et al., 1988). As a control for a possible
background level of DNA alterations, the Southern blots of
PvuII and MspI digested DNA were hybridised with the
VNTR probes pYNZ2, which maps to a sequence on chromo-
some lp, (Nakamura et al., 1988) and pYNH24 which maps
to a sequence on chromosome 2p (Nakamura et al., 1987),
respectively (Table II).
The probes were radioactively labelled with [M32P]dCTP
according to the random labelling method (Feinberg &
Vogelstein, 1983). Prehybridisations (2 h) and hybridisations
(overnight) were carried out in 0.5 M NaHPO4, pH 7.2,
0.001 M EDTA, 7% Sodium Dodecyl Sulfate (SDS), and 1%
Bovine Serum Albumin (BSA) at 65°C. After hybridisation,
the filters were washed for 10-15 min at 65°C in a 0.04M
NaHPO4 solution, pH 7.2, containing 1% SDS. X-ray films
(Kodak, XAR-5, Eastman Kodak Company, Rochester, NY,
USA) were exposed to the radiolabelled filters for 1-7 days
at -70°C using intensifying screens (Kodak).
Densitometric measurements andscoring criteria
Densitometric measurements were performed on all the heter-
ozygote cases using a Bio-Rad 1650 scanning densitometer.
The membranes were rehybridised with an additional probe
to adjust for differences in DNA loading (Table II). When
the ratio between the allele ratios of normal and tumour
DNA was > 1.5, a significant change was scored. This ratio
Table II Restriction endonucleases and VNTR DNA probes used
Detected Probe used
Chromosomal Restriction level of as correction
Probea location endonuclease heterozygosity for loading"
p68RS2.0 13ql4.2 RsaI 0.61 pYNZ2
(DlS57)
pYNZ2 lp PvuII 0.71 pTHH59
(DIS57) (D17S4)
pYNH24 2p MspI 0.93 pRMU3
(D2S44) (D17S24)
aIn the brackets are given the D-numbers according to the nomen-
clature of the HGM1O (1989).
was chosen to be able to score a tumour with the change in
question common for one-third or 50% (reduction or in-
crease in hybridisation intensity, respectively) or more of the
tumour cells (with regard to allelic amplification, assuming
that the affected cells each had one extra copy of the DNA
segment analysed). After adjustment for amount of DNA
loaded, the genetic change was scored as either allelic ampli-
fication, when an increase in hybridisation intensity of one
allele was observed, or loss of heterozygosity, when a reduc-
tion was observed (Figure 1).
Flow cytometric analysis
Flow cytometric analysis was performed on the ethanol fixed
cell suspensions according to the method described by Criss-
man and Steinkamp (1982), and modified by Kirkhus et al.
(1988). The cells were incubated with RNAase, 190,gml-'
(Boehring, Mannheim, Germany), for 30 min in dark in
20°C, and thereafter stained with the fluorochrome propi-
dium iodide, 17 lAgml- (Sigma Chemical Co., St Louis, MO,
USA), for 1 h on ice in dark. The emission of red fluore-
scence was measured in an Ortho Cytofluorograph 50H
(Ortho Instruments, Westwood, MA, USA). Mouse spleen
lymphocytes were used as an external diploid (2c) DNA
control.
Definition ofaneuploidy
The cellular amount of DNA was expressed as a DNA index
(Hiddemann et al., 1984). The DNA index is the ratio
between the mean relative DNA content of the cell popula-
tion examined and the mean DNA content of the diploid
reference cells. The peak with the lowest DNA content was
referred to as the diploid reference cell population (Meling et
al., 1991). The mean coefficient of variation (CV) of the
diploid peak was 3.2 (range 1.1-5.5). A tumour was defined
as aneuploid (Figure 2b) if a second distinct population ofG,
cells was present, and had a DNA index> 1.10 (Kirkhus et
al., 1988; Meling et al., 1991). Otherwise the tumour was
defined as near diploid (Figure 2a). This definition is at
variance with the definition of aneuploidy based on cyto-
genetic criteria, which defines tumours with any deviation
from the exact multiple of the haploid chromosome number,
as aneuploid (Thompson & Thompson, 1980).
In the DNA histogram analysis, minor peaks at the 4c
level (Figure 2a) may represent either G2 cells of the diploid
GI population, or GI cells of a tetraploid (aneuploid) cell
population, or a combination of the two. To differentiate
between an aneuploid cell population with tetraploid DNA
content and G2 cells of the diploid population in the DNA
histograms, planimetry was used (G6hde, 1973). When the
area below the 4c peak was larger than the area between the
2c and 4c levels (S-phase), the 4c peak was considered to
represent an aneuploid cell population. The rationale for this
is that in proliferating mammalian cells, the proportion of
cells in G2 phase is generally lower than that in the S-phase
(Steel, 1977).
Statistical analysis
For comparison between distributions, the x2 test was
applied.
Results
Proportions oftumour cells and non-tumour cells
The cell suspensions contained a mean of 84% tumour cells
(range 62 to 97%) with a normal distribution among the 18
different samples analysed. The non-tumour cells comprised a
mean of 9% mononuclear leukocytes (range 3 to 24%), 1%
granulocytes (range 0 to 4%), and 6% cells of undetermined
origin (range 0 to 18%). The majority of the latter cells
which had small and pycnotic nuclei, most likely represented
tumour cells or small inflammatory cells.RETINOBLASTOMA GENE IN COLORECTAL CARCINOMAS 477
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Figure 1 Allelic changes within the Rb locus detected by the
VNTR probe p68RS2.0 on RsaI blots. DNA from normal (N)
and tumour (T) tissue of four patients, all constitutionally
heterozygote are shown. Rehybridisation with the probe pYNZ2
were performed to adjust for the amount of DNA loaded. Patient
Cl 166 has no detectable change in the tumour. Patient C1088 has
an amplification of one allele (2.0 fold increase in hybridisation
intensity). Patient C1365 has an amplification of one allele (2.1
fold), and loss of the other allele. Patient C950 has lost one allele.
Intratumoural homogeneity
In seven of the eight carcinomas, no intratumoural variation
was found in any of the loci analysed. In one carcinoma,
heterozygous loss was found in the locus detected by probe
pYNZ2 in four of five samples, while the findings in the
other two loci were equal in all five samples.
Southern analysis
Of the 255 samples of tumour DNA and corresponding
normal DNA tested, the proportions of heterozygote (infor-
mative) cases were as follows: 156 (61.2%) for the VNTR
locus within the Rb gene, 180 (70.6%) for the VNTR locus
detected by the probe pYNZ2, and 236 (92.5%) for the
VNTR locus detected by the probe pYNH24 (Table II). The
proportions of tumours with genetic changes are given as
proportions of these informative cases.
200
Figure 2a Typical DNA histogram from one near diploid car-
cinoma. The histogram shows a single near diploid cell popula-
tion (2c) and its corresponding G2 fraction (4c). b, typical DNA
histogram from one aneuploid carcinoma. The first peak
represents a diploid cell population (2c), and the second an
aneuploid cell population (AN) (DNA index = 1.6). The two
smaller peaks to the right represent cell clumping and the G2
fraction of the aneuploid cell population, respectively.
Amplification of one allele within the Rb locus was found
in 46 of 156 cases (29.5%) (Figure 1 and Tables III and IV).
The mean increase in hybridisation intensity of the amplified
allele was 2.4-fold (range 1.5 to 4.2). Nine (5.8%) of the
tumours with allelic amplification had lost the other allele. A
total of 18 tumours (11.5%) had loss of one allele within the
Rb locus (Figure 1 and Tables III and IV).
In the pYNZ2 locus on chromosome Ip, three of 180
carcinomas (1.7%) demonstrated allelic amplification, with
increases in hybridisation intensity of2.4, 3.8 and 4.0, respec-
tively. One (0.6%) of these tumours had in addition loss of
the other allele. A total of 40 tumours (22.2%) had heter-
ozygous loss at this locus (Table III).
In the pYNH24 locus on 2p, six of 236 tumours (2.5%)
had amplification of one allele, of which three (1.2%) had
lost the other allele. The mean increase in hybridisation
intensity was 3.0-fold (range 1.6 to 5.8). At this locus, 37
tumours (15.7%) had loss of heterozygosity (Table III).
The frequency of changes on chromosome lp and 2p were
similar in tumours with changes in the Rb locus (n = 55)
(Table IV) and in those without changes in the Rb locus
(n = 101, individual data not shown) (X2 = 0.7, n.s. and
X2= 0.05, n.s., respectively).
The frequency of allelic amplification was significantly
higher within the Rb locus than on chromosomes lp and 2p,
respectively (X2 = 51.9, P<0.0001 and X2 = 59.3, P<0.0001).
Similar frequencies of allelic loss were found within the Rb
locus and at the locus on chromosome 2p (x2 = 1.3, n.s.).
There were significantly more tumours with heterozygous loss
on chromosome Ip than within the Rb locus (X2 = 6.7,
P<0.01), and there tended to be more tumours with heter-
-No-l I
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TableIII Frequenciesofgeneticalterationsfoundinthe255 colorectal
carcinomas
Heterozygous Amplification
Probe Amplification loss and loss Total
p68RS2.0 29.5% 11.5% 5.8% 35.3%
pYNZ2 1.7% 22.2% 0.6% 23.3%
pYHN24 2.5% 15.7% 1.2% 16.9%
ozygous loss on chromosome Ip than on chromosome 2p
(X2=2.9, P<0.1).
DNA ploidy pattern andgenetic alterations
One hundred and sixty of the 255 carcinomas (62.7%) had
aneuploid DNA pattern as demonstrated by DNA flow cyto-
metric analysis (Figure 2).
A significant association was found between amplification
within the Rb gene and DNA aneuploidy, as 36 of 46
tumours (78.3%) with allelic amplification were aneuploid,
compared to 55 of 101 tumours (54.5%) without genetic
changes in the Rb locus (X2 = 7.6, P<0.01) (Table V).
Significantly more tumours with heterozygous loss on
chromosomes lp (X2 = 11.3, P<0.001) and 2p (X = 9.0,
P<0.01) were aneuploid (85% and 83.8%, respectively) than
those without alterations on these chromosomes (55.8% and
57.7%, respectively).
Of a total of 57 aneuploid tumours that were informative
at all three loci, 23 (40.4%) had amplification within the Rb
gene. Only one tumour (2.1%) showed allelic amplification
on chromosome lp, and another one (2.1%) showed allelic
amplification on chromosome 2p.
Genetic alterations and clinicopathological characteristics
Similar distributions of Dukes' stage, histological grade,
degree of cellular atypia, and tumour localisation were found
in the tumours with amplification in the Rb locus (n = 46)
compared with those without Rb gene changes (n = 101)
(Table V).
Discussion
Colorectal carcinomas are likely to develop as a result of
progressive accumulation of several genetic alterations (for
review, see Fearon & Vogelstein, 1990). The majority of
genetic changes detected have involved mutational inactiva-
tion or loss of putative tumour suppressor genes. So far,
however, only few cases of gene amplifications have been
reported, involving only oncogenes. Consequently, amplifi-
cations have been assumed to play a minor role in colorectal
carcinogenesis.
The retinoblastoma gene acts as a tumour suppressor gene,
and is known to be involved in several human malignancies
(for reviews, see Benedict et al., 1990; Marshall, 1991). In a
cytogenetic study on colorectal carcinomas, a non-random
gain of chromosome 13 has been demonstrated (Muleris et
al., 1988), and in a smaller colorectal carcinoma study, a
significant amplification of the Rb gene was demonstrated
both at the DNA and RNA levels (Gope et al., 1990), both
studies suggesting that the Rb gene may be involved in
colorectal carcinogenesis. The findings of the latter report
have recently been confirmed by Lothe et al. (1991). Further-
more, loss of one chromosome 13 during development of a
polyposis tumour has earlier been reported (Lothe et al.,
1987).
In our study of 255 colorectal carcinomas, we found
genetic alterations within the Rb locus in 35.3% of the
informative tumours. The majority of these tumours (46 of
55, 84%) had amplification of one allele, whereas only nine
(16%) had heterozygous loss within the Rb locus without
allelic amplification of the remaining allele. Our results there-
fore confirm that the Rb gene may be involved in colorectal
Table IV DNA ploidy patterns and genetic alterations in the 55
colorectal carcinomas with changes within the Rb locus
Patient DNA Rb Fold increase of ip 2p
code ploidy changes one Rb allele changes changes
C 848
C 887
C 922
C 936
C 937
C 940
C1008
C1O0O
C1013
C1025
C1041
C1045
C1048
C1088
C1089
C1096
C1102
Cl 194
Cl195
C1263
C1284
C1291
C1302
C1332
C1334
C1340
C1364
C1382
C1400
C1403
C1406
C 850
C 946
C1099
C1276
C1324
C1343
C 904
C1014
Cl 120
Cl 168
C1365
C 945
C 982
C1024
C1103
C914
Cs155
C1290
C1447
C858
C 950
C 965
C1030
C1389
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
AN
ND
ND
ND
ND
ND
ND
AN
AN
AN
AN
AN
ND
ND
ND
ND
AN
AN
AN
AN
ND
ND
ND
ND
ND
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
A
A
A
A
A
A
A
A
A
1.8
2.1
3.7
2.0
1.5
4.0
4.2
2.0
1.6
3.5
2.0
2.4
2.6
2.0
1.8
2.0
2.9
3.5
3.5
2.3
3.9
2.5
4.0
3.0
2.0
2.0
2.0
2.5
2.2
1.9
3.3
1.9
1.8
1.5
2.0
2.0
2.5
2.3
2.5
2.0
4.0
2.1
2.0
2.0
2.3
2.1
Information about the carcinomas are given, where a genetic
alteration was detected with the probe p68RS2.0, homologous to a
VNTR region within the Rb gene; AN: aneuploid DNA pattern; ND:
near diploid DNA pattern; 0: Heterozygote with allelic amplification
of one allele; A: Loss of heterozygosity and amplification of the
remaining allele; *: Loss of heterozygosity; -: Homozygote; +:
Heterozygote without changes.
carcinogenesis, and furthermore, that allelic amplification is
the genetic change of importance.
In other malignancies with assumed involvement of the Rb
gene in the tumourigenesis, loss of heterozygosity has been
demonstrated, indicating a tumour suppressor gene activity
of the Rb gene (Hansen & Cavenee, 1987). Since hetero-
zygous loss within the Rb gene does not occur more fre-
quently than in random genes of chromosome 1 or 2, there
seems to be no role for the Rb gene as a tumour suppressor
gene in colorectal carcinomas. In the present study, however,
we found that allelic amplification was by far the most
common change within the Rb gene. Since amplification is aRETINOBLASTOMA GENE IN COLORECTAL CARCINOMAS 479
Table V Clinicopathological characteristics ofthe patients according
to amplification within the Rb gene
No. ofcases
with amplification without Rb
Clinicopathological within the RB gene gene changes Level of
characteristics n = 46 (%) n = 101 (%) sign.
DNA ploidy pattern
Aneuploid 36 (78) 55 (54) p<0.01
Near diploid 10 (22) 46 (46)
Dukes' stage A 3 (6) 14 (14)
B 23 (50) 38 (37)
C 11 (24) 34 (34) n.s D 9 (20) 15 (15)
Histological grade
Well differentiated 1 (2) 4 (4)
Moderately diff. 44 (96) 84 (83)
Poorly diff. 1 (2) 13 (13) n.s.
Degree ofcellular atypia
Slight 3 (6) 3 (3)
Moderate 26 (57) 74 (73) n.s.
Severe 17 (37) 24 (24)
Localisation
Right colon 8 (17) 31 (31) ns
Left colon 14 (31) 23 (23) n.s
Rectum 24 (52) 47 (46)
phenomenon known to be associated with some oncogenes,
our results suggest that the Rb gene may have an oncogene-
like effect in colorectal carcinomas. Another gene involved in
colorectal tumourigenesis, the p53 gene located on chromo-
some 17, has previously been shown to be able to act both as
a tumour suppressor gene as well as, in a mutated form, an
oncogene (for review, see Levine, 1990). Our demonstration
of an increased copy number of a VNTR region within the
Rb gene suggests that this region or the whole gene may be
involved in local rearrangements, or that the carcinoma cells
may contain increased copy numbers of large portions of
chromsome 13. Preliminary data from our laboratory, how-
ever, indicate that amplification within the Rb locus does not
commonly involve DNA sequences flanking the gene (data
not shown), but indeed involves other DNA sequences within
the gene itself (Lothe et al., 1991). This makes it unlikely that
the Rb gene is merely coamplified together with another
possible oncogene located on chromosome 13. It has also
recently been demonstrated that the DNA sequence detected
by the VNTR probe p68RS2.0 contains possible hot spots
for structural aberrations (T'Ang et al., 1989).
We have earlier reported a higher proportion ofcells in the
S-phase of the cell cycle in aneuploid carcinomas compared
with near diploid ones (Refsum et al., 1984; Rognum et al.,
1984). In this study, we could demonstrate a significant
association between amplification within the Rb gene and
DNA aneuploidy. It has been assumed that both the Rb gene
protein and p53 negatively regulate the passage of cells
through the cell cycle (Mihara et al., 1989; Diller et al.,
1990). In aneuploid carcinomas, an amplified Rb gene may
have an adverse effect, and enhance the number of cells that
go through the S-phase, either directly, or indirectly through
an interaction with and inactivation of p53.
Among the 57 aneuploid tumours informative at all three
loci analysed, we could demonstrate only two carcinomas
with DNA amplification on chromosomes lp and 2p, respec-
tively. This suggest that the observed gain in total DNA
content in aneuploid cells is not merely the result of random
amplification of the diploid genome.
The frequency of heterozygous loss was higher on chromo-
some Ip than on chromosome 2p and within the Rb gene.
This is in correspondence with the recently reported loss on
chromosome lp in 42% of colon carcinomas (Leister et al.,
1990). Also, in several other solid tumours, heterozygous loss
or cytogenetic deletions on chromosome lp has been assoc-
iated with tumour development (Brodeur et al., 1981;
Mathew et al., 1987; Trent et al., 1989). In the present study,
allelic loss on chromosome 1 was significantly associated with
DNA aneuploidy. Therefore, loss of DNA sequences on
chromosome 1 may be of importance for aneuploidy in a
subset of aneuploid colorectal carcinomas.
In conclusion, our results suggest that the Rb gene is
involved in colorectal carcinogenesis. As allelic amplification
was found to be the most frequent change within the Rb
locus, the mechanism for involvement of this gene is prob-
ably different in colorectal carcinomas compared with retino-
blastomas. Our results also indicate that the increased
amount of DNA present in aneuploid cell populations may
constitute specific gene amplifications of importance in the
colorectal carcinogenesis. Follow-up studies are already in
progress to evaluate the possible prognostic significance of
amplifications within the Rb gene in colorectal carcinomas.
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